Aull & Monroe Investment Management Corp decreased its position in Procter & Gamble Company (The) (NYSE:PG - Free Report) by 13.1% during the 2nd quarter, according to the company in its most recent filing with the SEC. The fund owned 27,724 shares of the company's stock after selling 4,173 shares during the quarter. Procter & Gamble accounts for approximately 2.4% of Aull & Monroe Investment Management Corp's holdings, making the stock its 11th biggest holding. Aull & Monroe Investment Management Corp's holdings in Procter & Gamble were worth $4,417,000 at the end of the most recent reporting period.
Several other large investors have also made changes to their positions in PG. Kingstone Capital Partners Texas LLC grew its holdings in shares of Procter & Gamble by 655,209.0% in the 2nd quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company's stock worth $11,832,680,000 after purchasing an additional 76,017,350 shares during the last quarter. Nuveen LLC bought a new stake in shares of Procter & Gamble in the 1st quarter worth about $1,954,941,000. Price T Rowe Associates Inc. MD grew its holdings in shares of Procter & Gamble by 13.0% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company's stock worth $3,660,737,000 after purchasing an additional 2,466,308 shares during the last quarter. Invesco Ltd. grew its holdings in shares of Procter & Gamble by 19.8% in the 1st quarter. Invesco Ltd. now owns 13,493,604 shares of the company's stock worth $2,299,580,000 after purchasing an additional 2,228,151 shares during the last quarter. Finally, Valeo Financial Advisors LLC grew its holdings in shares of Procter & Gamble by 1,875.5% in the 2nd quarter. Valeo Financial Advisors LLC now owns 1,763,404 shares of the company's stock worth $280,946,000 after purchasing an additional 1,674,139 shares during the last quarter. Institutional investors own 65.77% of the company's stock.
Analysts Set New Price Targets
PG has been the topic of a number of research analyst reports. Barclays decreased their price objective on shares of Procter & Gamble from $164.00 to $153.00 and set an "equal weight" rating on the stock in a report on Wednesday, October 1st. Bank of America decreased their price objective on shares of Procter & Gamble from $180.00 to $174.00 and set a "buy" rating on the stock in a report on Wednesday, October 8th. JPMorgan Chase & Co. decreased their price objective on shares of Procter & Gamble from $170.00 to $163.00 and set a "neutral" rating on the stock in a report on Friday, October 10th. Evercore ISI reissued an "in-line" rating and set a $170.00 price objective (down previously from $190.00) on shares of Procter & Gamble in a report on Monday, July 14th. Finally, BNP Paribas Exane decreased their price objective on shares of Procter & Gamble from $177.00 to $172.00 and set an "outperform" rating on the stock in a report on Tuesday, September 23rd. Eleven research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. According to MarketBeat.com, Procter & Gamble has a consensus rating of "Moderate Buy" and a consensus target price of $172.21.
Get Our Latest Analysis on Procter & Gamble
Procter & Gamble Stock Performance
Procter & Gamble stock opened at $151.53 on Friday. The company has a current ratio of 0.70, a quick ratio of 0.49 and a debt-to-equity ratio of 0.49. Procter & Gamble Company has a 1 year low of $146.96 and a 1 year high of $180.43. The company has a market cap of $354.66 billion, a PE ratio of 23.28, a PEG ratio of 4.02 and a beta of 0.36. The company's 50-day moving average is $154.92 and its two-hundred day moving average is $158.77.
Procter & Gamble (NYSE:PG - Get Free Report) last released its earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.42 by $0.06. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The company had revenue of $20.89 billion for the quarter, compared to the consensus estimate of $20.79 billion. During the same period in the prior year, the company posted $1.40 EPS. The company's revenue was up 1.7% compared to the same quarter last year. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Equities analysts anticipate that Procter & Gamble Company will post 6.91 earnings per share for the current year.
Procter & Gamble Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Monday, November 17th. Shareholders of record on Friday, October 24th will be given a dividend of $1.0568 per share. The ex-dividend date is Friday, October 24th. This represents a $4.23 dividend on an annualized basis and a yield of 2.8%. Procter & Gamble's dividend payout ratio is presently 64.98%.
Insider Activity at Procter & Gamble
In related news, CEO Jon R. Moeller sold 40,119 shares of the stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total value of $6,309,515.13. Following the sale, the chief executive officer directly owned 319,375 shares in the company, valued at $50,228,106.25. This trade represents a 11.16% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, COO Shailesh Jejurikar sold 13,039 shares of the stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total transaction of $2,050,643.53. Following the completion of the sale, the chief operating officer owned 28,036 shares in the company, valued at $4,409,221.72. This represents a 31.74% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 149,763 shares of company stock worth $23,421,279. Insiders own 0.20% of the company's stock.
About Procter & Gamble
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Further Reading
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report